![Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts | BMC Endocrine Disorders | Full Text Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts | BMC Endocrine Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12902-019-0338-7/MediaObjects/12902_2019_338_Fig1_HTML.png)
Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts | BMC Endocrine Disorders | Full Text
![Mark Mills on Twitter: "As a trainee, I still find type 2 diabetes / HbA1c targets / different therapies stupidly complicated to make sense of - particularly as we really on the Mark Mills on Twitter: "As a trainee, I still find type 2 diabetes / HbA1c targets / different therapies stupidly complicated to make sense of - particularly as we really on the](https://pbs.twimg.com/media/EAA6X1zXYAAYyMD.jpg)
Mark Mills on Twitter: "As a trainee, I still find type 2 diabetes / HbA1c targets / different therapies stupidly complicated to make sense of - particularly as we really on the
![Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes | npj Digital Medicine Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes | npj Digital Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41746-022-00606-9/MediaObjects/41746_2022_606_Fig1_HTML.png)
Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes | npj Digital Medicine
![HbA1c Targets for Glycemic Control With Pharmacologic Therapy for Type 2 Diabetes: An Update From the ACP | PracticeUpdate HbA1c Targets for Glycemic Control With Pharmacologic Therapy for Type 2 Diabetes: An Update From the ACP | PracticeUpdate](http://cloudfront.practiceupdate.net/contentimage/16170.jpg)
HbA1c Targets for Glycemic Control With Pharmacologic Therapy for Type 2 Diabetes: An Update From the ACP | PracticeUpdate
![Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40) | BMJ Open Diabetes Research & Care Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40) | BMJ Open Diabetes Research & Care](https://drc.bmj.com/content/bmjdrc/4/1/e000294/F1.large.jpg)
Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40) | BMJ Open Diabetes Research & Care
![The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review | RCP Journals The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review | RCP Journals](https://www.rcpjournals.org/content/clinmedicine/22/3/257/F2.large.jpg)
The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review | RCP Journals
![60F presents for a review of type 2 diabetes mellitus. Bloods show an HbA1c of 8.5%. What's your approach? Open this thread and I'll share mine. - Thread from Josh Inglis @inglisjosh - Rattibha 60F presents for a review of type 2 diabetes mellitus. Bloods show an HbA1c of 8.5%. What's your approach? Open this thread and I'll share mine. - Thread from Josh Inglis @inglisjosh - Rattibha](https://pbs.twimg.com/media/FLEp3h1XIAMC04h.jpg)